Canopus Biopharma, Inc.

Canopus Biopharma, Inc.

CBIA
Canopus Biopharma, Inc.US flagOther OTC
0.00
USD
- -
- -
455,071.00Market Cap

Canopus Biopharma, Inc. (CBIA) Stock Split History

Learn about Canopus Biopharma, Inc.'s most recent 1-for-15 basis stock split on July 16, 2007. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Canopus Biopharma, Inc.'s most recent stock split

Split Date: 2007-07-16
Split Ratio: 1:15
Price Before Split: N/A
Price After Split: N/A

Developer API

Get CBIA split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/CBIA

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 15.00 times fewer shares (a 1:15 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Canopus Biopharma, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2007-07-161:15YesN/AN/A

About Canopus Biopharma, Inc.

Company overview and industry information

Canopus Biopharma, Inc. (CBIA) operates in the Medical - Pharmaceuticals industry. The recent 1-for-15 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Medical - Pharmaceuticals
Go to Canopus Biopharma, Inc. Summary

Last updated: 7/21/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.